Trial intelligence / Profile preview

Inpatient versus outpatient misoprostol for first-trimester abortion induction

IRCT20180109038284N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of misoprostol in Induced Abortion (TOP) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Success rate of spontaneous abortion with misoprostol, Need for transfusion and 1 more. Started Nov 2017; status: completed.

02

Drugs

misoprostol
03

Conditions

Induced Abortion (TOP)

Beyond the preview

Go deeper on IRCT20180109038284N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180109038284N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call